医学
干扰素
肉瘤
免疫学
血清学
重组DNA
鼻咽癌
病毒学
发病机制
α-干扰素
病毒性疾病
病毒
乳头状瘤
病理
放射治疗
抗体
基因
内科学
生物
生物化学
作者
Susan E. Krown,Francisco X. Real,Susanna Cunningham–Rundles,Patricia L. Myskowski,Benjamín Koziner,Seymour Fein,Abraham Mittelman,Herbert F. Oettgen,Bijan Safai
标识
DOI:10.1056/nejm198305053081806
摘要
Preliminary clinical trials have shown that both natural and recombinant-DNA-produced human interferons are occasionally capable of inhibiting the growth of some tumors.1 2 3 4 Although the tumors responding to interferon have most often been those without evidence for a viral association, case reports have appeared of therapeutic effects in patients with nasopharyngeal carcinoma,5 for which there is strong serologic evidence supporting a viral association, and in patients with laryngeal papilloma,6 for which the available evidence supports a viral pathogenesis. Interferons have also been shown to modify the course of chronic viral infections in human beings, including infections induced by hepatitis B virus . . .
科研通智能强力驱动
Strongly Powered by AbleSci AI